Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Head-to-head for women
Edessa vs Lttl
Edessa and Lttl both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Edessa
Ranked #74 for women · Grade C
Luna Fit
Best for: A woman prepared to prepay six months, or one willing to click past the front page to the table carrying the real monthly rate.
Visit EdessaLttl
Higher scoreRanked #21 for women · Grade B−
Luna Fit
Best for: Readers treating insulin resistance who want the month-to-month rate rather than a prepay rung, and who will open the plan selector: the real ladder is public, complete and honest, and it is one click from a headline figure that is not.
Visit LttlThe verdict for women
Lttl edges out Edessa on the Luna Fit Score, 81 to 69 (B− vs C). Readers treating insulin resistance who want the month-to-month rate rather than a prepay rung, and who will open the plan selector: the real ladder is public, complete and honest, and it is one click from a headline figure that is not. The reasoning behind that number is in our Lttl write-up for women.
Edessa is still a genuine option — clean three-rung tables one click in, behind a front page whose three cards all quote six-month rungs and whose cheapest belongs to a different drug. Weigh the six women's-health factors below against your own priorities; what we found reviewing Edessa goes through each of them, and if neither of these two is the one, what women pick instead of Edessa widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Edessa | Lttl |
|---|---|---|
| Luna Fit Score | 69/100 · C | 81/100 · B− |
| Overall rank | #74 | #21 |
| Semaglutide | $179/mo month-to-month for the injection ($135 only on a six-month prepay) | $199/mo month-to-month (from $129/mo on a 12-month plan billed $1,548 up front) — the product card advertises the $129 rung |
| Tirzepatide | $239/mo month-to-month ($209 only on a six-month prepay) | $279/mo month-to-month (from $199/mo on a 12-month plan billed $2,388 up front) — the product card advertises $129, which no tirzepatide tier costs |
| Coverage | Not publicly listed | All 50 states plus Washington D.C., with a stated caveat that some services may not be |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Luna Fit
Edessa
Ranked #74 · Grade C
What we like
- Each product page carries a plain three-rung table, so the commitment behind every figure is visible
- "Same price, every dose" is printed on each product page
- Names its operating entity and a full street address in Las Vegas, Nevada
The caveats
- The front page leads with "Start for just $135", a six-month prepay on the semaglutide injection; month-to-month tirzepatide is $239
- All three front-page cards quote the six-month rung, so the real monthly rates appear only after a click
- Its Terms give two corporate forms for the same company in one clause — "Edessa Group, LLC, a Nevada corporation"
Luna Fit
Lttl
Ranked #21 · Grade B−
What we like
- Publishes its entire price ladder — every product, every term, every rung — in the public page source, each one labeled with what it bills (“$199/mo every month” beside “$1,548 annually”), with no intake quiz standing between you and the number
- A genuine month-to-month rung exists and is purchasable for every product, with no contracts and no minimum term, so the prepay ladder is an optional discount rather than the only way in
- Both molecules across three routes — injection, orally disintegrating tablet, and lower-dose microdose lines sold as their own products with their own published ladders rather than quoted at the full-dose price
The caveats
- All fourteen product cards hardcode “from $129/mo”. For semaglutide that is the twelve-month rung billed $1,548 up front; for tirzepatide, the semaglutide ODT and the microdose ODT it is a price purchasable at no tier at all
- The month-to-month rates are roughly 40% above the advertised figure — $199 for semaglutide and $279 for tirzepatide against the $129 on every card
- Names no medical director and no prescribing clinician, offers and requires no labs or bloodwork, and carries no third-party certification such as LegitScript
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither Edessa nor Lttl is only worth comparing with the other. Edessa is also written up against CoreAge Rx, 24 points apart on the Luna Fit Score — see how Edessa and CoreAge Rx compare on the Luna Fit Score. Lttl is also written up against CoreAge Rx, 12 points apart — see Lttl against CoreAge Rx, factor by factor.
- Edessa vs CoreAge Rx
- Edessa vs Enhance MD
- Edessa vs Eden
- Lttl vs yourEra
- Lttl vs Sesame Care
- Lttl vs HealthRX
Or browse the full comparison hub.